Imagen de Portada

Pooled in vitro and in vivo CRISPR-Cas9 screening identifies tumor suppressors in human colon organoids

Colorectal cancer (CRC) is characterized by prominent genetic and phenotypic heterogeneity between patients. To facilitate high-throughput genetic testing and functional identification of tumor drivers, we developed a platform for pooled CRISPR-Cas9 screening in human colon organoids. Using transfor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michels, Birgitta E. (Autor) , Mosa, Mohammed H. (Autor) , Streibl, Barbara I. (Autor) , Zhan, Tianzuo (Autor) , Menche, Constantin (Autor) , Abou-El-Ardat, Khalil (Autor) , Darvishi, Tahmineh (Autor) , Członka, Ewelina (Autor) , Wagner, Sebastian (Autor) , Winter, Jan (Autor) , Medyouf, Hind (Autor) , Boutros, Michael (Autor) , Farin, Henner F. (Autor)
Formato: Article (Journal)
Lenguaje:inglés
Publicado: 7 May 2020
In: Cell stem cell
Year: 2020, Volumen: 26, Número: 5, Pages: 782-792
ISSN:1875-9777
DOI:10.1016/j.stem.2020.04.003
Acceso en línea:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.stem.2020.04.003
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1934590920301429
Enlace del recurso
Notas de Autor:Birgitta E. Michels, Mohammed H. Mosa, Barbara I. Streibl, Tianzuo Zhan, Constantin Menche, Khalil Abou-El-Ardat, Tahmineh Darvishi, Ewelina Członka, Sebastian Wagner, Jan Winter, Hind Medyouf, Michael Boutros, Henner F. Farin
Descripción
Sumario:Colorectal cancer (CRC) is characterized by prominent genetic and phenotypic heterogeneity between patients. To facilitate high-throughput genetic testing and functional identification of tumor drivers, we developed a platform for pooled CRISPR-Cas9 screening in human colon organoids. Using transforming growth factor β (TGF-β) resistance as a paradigm to establish sensitivity and scalability in vitro, we identified optimal conditions and strict guide RNA (gRNA) requirements for screening in 3D organoids. We then screened a pan-cancer tumor suppressor gene (TSG) library in pre-malignant organoids with APC−/−;KRASG12D mutations, which were xenografted to study clonal advantages in context of a complex tumor microenvironment. We identified TGFBR2 as the most prevalent TSG, followed by known and previously uncharacterized mediators of CRC growth. gRNAs were validated in a secondary screen using unique molecular identifiers (UMIs) to adjust for clonal drift and to distinguish clone size and abundance. Together, these findings highlight a powerful organoid-based platform for pooled CRISPR-Cas9 screening for patient-specific functional genomics.
Notas:Gesehen am 10.06.2020
Descripción Física:Online Resource
ISSN:1875-9777
DOI:10.1016/j.stem.2020.04.003

Ejemplares similares